butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine has been researched along with Influenza, Human in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, MC; Courtin, N; Fautrad, P; Fotso, AF; Mas, F; Riteau, B | 1 |
1 other study(ies) available for butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine and Influenza, Human
Article | Year |
---|---|
Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
Topics: A549 Cells; Animals; Antiviral Agents; Cell Survival; Dogs; Drug Combinations; Female; Gelsolin; Haplorhini; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Madin Darby Canine Kidney Cells; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Oligopeptides; Oseltamivir; Peptide Fragments; Receptors, Formyl Peptide; Receptors, Lipoxin; Sequence Alignment; Virus Replication | 2017 |